Mwandishi
Mhariri:
Imeboreshwa:
ULY CLINIC
ULY CLINIC
Jumatano, 15 Julai 2026, 2:43:25 GMT +3
Antibacterial medicine lists
Antibacterial medicine lists
Access Group Antibiotics
Name of drug | Dosage forms and Strengths | Level of medicine |
Ampicillin | Powder for injection (as sodium salt) 250mg, 500mg in vial | A |
Ampicilin + cloxacillin |
Capsule 250/250mg, injection | B |
Amoxicillin | Capsule (as trihydrate) 250mg; Dispersible tablet 250mg, 125mg | A |
Amoxicillin + Clavulanic acid | Powder for suspension (as trihydrate) 125mg+ 31.25mg (as potassium salt) in 5mL AND 250mg amoxicillin + 62.5mg clavulanic acid/5mL; Tablet (as trihydrate) 500mg + 125mg clavulanic acid (as potassium salt) | B |
Amoxicillin + Clavulanic acid | Powder for injection 500mg (as sodium), + 100mg (as potassium salt) in vial | C |
Benzathine benzyl penicillin | Powder for injection 1.44g (2,400,000 IU) in vial | A |
Benzyl Penicillin | Powder for injection (as sodium or potassium salt) 3g (5,000,000 IU) in vial | A |
Cephalexin | Capsule 250mg (as monohydrate); Powder for reconstitution 125/5mi; 250mg/mL | B |
Cloxacillin | Powder for injection (as sodium salt) 250mg, 500mg in vial | B |
Doxycycline | Capsule (as hydrochloride), 100mg | A |
Erythromycin | Powder for suspension (as ethylsuccinate), 125mg/5mL in 100mL bottle; Tablet (as stearate or ethyl succinate), 250mg, film coated | A |
Flucloxacillin + Amoxicillin | Tablet 500mg (as combination) ; | C |
Flucloxacillin | Injection (sodium) 250mg; 125mg/5mL Oral solution | C |
Metronidazole | Suspension as (benzoate) 200mg/5mL in 100mL; Tablet 200mg | A |
Injection (I.V) 5mg/mL in 100mL bottle; | B | |
Nitrofurantoin | Tablet 100mg | A |
Phenoxymethylpenicillin | Powder for suspension 125mg/5mL; (as potassium salt), Tablet 250mg | A |
Tetracycline | Capsule 250mg | S |
Watch Group Antibiotics
Name of drug | Dosage forms and Strengths | Level of medicine |
Ampicillin + Sulbactum | Powder for injection (ampicillin 1g/sulbactam 0.5g), (ampicillin 2g/sulbactam 1g), (ampicillin 10g/sulbactam 5g) | C |
Azithromycin | Capsule/Tablet (as dihydrate) 250mg, 500mg; Oral liquid 200mg/5mL | B ( level A for STI only) |
Clarithromycin | Tablet 250mg, 500mg | C |
Chloramphenicol | Oily injection 0.5g (as sodium succinate)/mL in 2mL ampoule; Powder for injection (as sodium succinate) 1g, 125mg/5mL injection (as Phosphate), 150mg/mL in 2mL ampule | B (Reserved for meningitis) |
Ceftriaxone | Injection 250mg, 500mg, 1g in vial | B ( level A for STI only) |
Ceftriaxone+sulbactam | Injection 1.5g vial | D |
Ciprofloxacin | Tablet (as hydrochloride) 250mg, 500mg | A |
Ciprofloxacin | Solution for IV infusion 2mg/mL in 100mL | C |
Gentamicin | Injection (as sulfate) 40mg/mL in 2mL ampoule, 20mg/mL in 2 mL ampoule | A |
Piperacillin + tazobactam | Powder for injection 2g (as sodium salt) + 250mg (as sodium salt); 4g (as sodium salt) + 500mg (as sodium salt) in vial | S |
Sulfamethoxazole + triemethoprim | Suspension (Sulphamethoxazole 200 mg/5mL + trimethoprim 40mg/5mL in 100mL bottle; Tablet 480mg; Sulphamethoxazole 400mg/trimethoprim 80mg | A |
Ceftazidime | Powder for injection (as pentahydrate) 250mg in vial | D |
Cefixime | Capsule 200mg/ 400mg | S (A for STI and Typhoid) |
Cefuroxime | Powder for Injection 250mg, 750mg, 1.5g (as sodium salt) in vial | D |
Cefuroxime | Oral suspension 125mg/5mL, 250mg/5mL; Tablet 250mg, 500mg; injection | D |
Reserve Group Antibiotics
Name of drug | Dosage forms and Strengths | Level of medicine |
Amikacin | Injection 250mg/mL (as sulfate) | S |
Cefepime | Injection 1000mg | S |
Clindamycin | Capsule 150mg (as hydrochloride); | S |
Injection (as phosphate) 150mg/mL in 2mL ampule | S | |
Colistin | Powder for Injection 1MIU per vial | S |
Dapsone | Tablet 100mg | S |
Meropenem | Injection 500mg, 1000mg | S |
Vancomycin | Capsule: 125mg; 250mg (as hydrochloride) | S |
Powder for injection 250mg (as hydrochloride) in vial | S |
Imeandikwa:
Jumatano, 3 Juni 2026, 18:16:32 GMT +3
References:

